Why the study?
Does intracoronary injection of autologous mononuclear bone marrow cells improve long-term left ventricular function in patients with anterior STEMI treated with PCI?
Does intracoronary injection of autologous mononuclear bone marrow cells improve long-term left ventricular function in patients with anterior STEMI treated with PCI?
Intracoronary injection of autologous mononuclear bone marrow cells does not improve long-term global, regional, or diastolic LV function in patients with anterior STEMI after PCI.
Answers are grounded in this paper and cite their sources.
Intracoronary mBMC injection is not indicated for long-term LVEF recovery after anterior STEMI; confirms neutral effect in this RCT.
AIMS: To clarify long-term changes in global, regional, and diastolic left ventricular (LV) function after intracoronary injection of autologous mononuclear bone marrow cells (mBMCs) in acute myocardial infarction (AMI). METHODS AND RESULTS: In the Autologous Stem cell Transplantation in Acute Myocardial Infarction (ASTAMI) study, 100 patients with anterior ST-elevation myocardial infarction and percutaneous coronary intervention on the left anterior descending artery (LAD) were randomized to receive intracoronary injection of mBMCs or not. Transthoracic echocardiography was performed at baseline, 3, 6, 12 months, and 3 years. Regional LV function was assessed by two-dimensional speckle-tracking echocardiography. From baseline to 3 years, LV ejection fraction changed from 45.7 to 47.5% in the mBMC group, and from 46.9 to 46.8% in the control group (P = 0.87 for difference in change over time between groups). Longitudinal strain in the LAD territory improved from -9.7 to -12.2% in the mBMC group and from -9.9 to -12.8% in the control group (P = 0.45). E/e' decreased from 14.7 to 12.9 in the mBMC group and from 14.8 to 11.9 in the control group (P = 0.31). There were no significant differences between groups in change of LV volumes, global systolic function, regional function, or diastolic function during 3 years follow-up. CONCLUSION: No differences between groups indicating beneficial effect of intracoronary mBMC injection could be identified. Both groups in ASTAMI experienced improvement of global, regional, and diastolic LV function after 3-6 months, with effects sustained at 3 years.
No takes yet. Share an insight, caveat, or question.
Beitnes et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: